LIFEVANTAGE CORP— Sankey Diagram
Quarterly mode · period ending 2025-12-31 · SEC EDGAR
ComparingFY2025 (Q4) vs FY2024 (Q4)
Revenue
$49M
↓-27.8% -$19Mvs FY2024 (Q4)
Gross Profit
$36M
↓-33.6% -$18Mvs FY2024 (Q4)
Operating Income
$487K
↓-85.8% -$3Mvs FY2024 (Q4)
Net Income
$276K
↓-89.2% -$2Mvs FY2024 (Q4)
Click a Metric or Sankey Node to View Historical Trends
Show Source Data (Audit Panel)
| Line item | FY2025 (Q4) | FY2024 (Q4) |
|---|---|---|
| Revenue | $49M | $68M |
| COGS | $13M | $13M |
| Gross Profit | $36M | $55M |
| R&D | $200K | $200K |
| SG&A | $16M | $19M |
| D&A | $752K | $806K |
| Other OpEx | $19M | $32M |
| Operating Income | $487K | $3M |
| Interest Exp. | $14K | $130K |
| Other Non-Op | $0 | $209K |
| Pretax Income | $473K | $3M |
| Tax | $197K | $539K |
| Net Income | $276K | $3M |
QuarterCharts · SEC EDGAR data · LFVN · Comparing FY2025 (Q4) vs FY2024 (Q4)